PSURs in India: CDSCO Expectations and PvPI Integration – pharmaceutical industry regulatory affairs PSURs in India: CDSCO Expectations and PvPI Integration Periodic Safety Update Reports (PSURs) play a crucial role in the ongoing safety assessment of pharmaceutical products. In India, the regulatory landscape surrounding PSURs is governed by the Central Drugs Standard Control Organization (CDSCO) and harmonized with international guidelines. This article serves as a comprehensive guide for pharmaceutical industry regulatory affairs professionals, detailing how to effectively prepare, submit, and manage PSURs, while ensuring alignment with the Pharmacovigilance Programme of India (PvPI). How to Prepare a PSUR in Compliance with…

PSUR-PV Inspection Readiness: Common Compliance Gaps – regulatory affairs in pharmaceutical industry PSUR-PV Inspection Readiness: Common Compliance Gaps How to Understand PSUR Requirements in Regulatory Affairs The Periodic Safety Update Report (PSUR) is a crucial document in the drug lifecycle management, reflecting the evolving understanding of the safety profile of a pharmaceutical product. Familiarity with its requirements is essential for ensuring compliance during inspections by regulatory authorities. Understanding the PSUR begins with familiarizing yourself with the guidelines set by prominent regulatory bodies such as the ICH and the FDA. These documents lay the groundwork for the expectations related to PSUR…

Lifecycle Management Through Periodic Safety Reports – regulatory affairs in pharma industry Lifecycle Management Through Periodic Safety Reports In the complex landscape of the pharmaceutical industry, regulatory affairs play a crucial role in ensuring drug safety and efficacy. Central to these efforts is the management of periodic safety reports, specifically Periodic Safety Update Reports (PSURs), which are vital for ongoing risk assessment and compliance with regulations set forth by authorities such as the FDA, EMA, and MHRA. This comprehensive manual is designed to guide pharmaceutical professionals through the intricacies of lifecycle management and reporting of safety data. How to Structure…

Automation in PSUR Generation: Tools and Best Practices – regulatory affairs in pharmaceutical industry Automation in PSUR Generation: Tools and Best Practices Periodic Safety Update Reports (PSURs) are integral to maintaining drug safety and compliance within regulatory frameworks. As regulatory requirements become more stringent, the automation of PSUR generation provides significant benefits, ensuring accuracy, efficiency, and conformity with applicable regulations. This guide offers a comprehensive how-to on the processes, tools, and best practices for automating PSUR generation for professionals in regulatory affairs in the pharmaceutical industry. How to Understand Regulatory Frameworks for PSURs To successfully automate PSUR generation, it is…

Submission via eCTD: Technical Aspects of PSUR Filings – regulatory affairs in pharma industry Submission via eCTD: Technical Aspects of PSUR Filings The pharmaceutical industry operates under a stringent regulatory environment. Understanding how to effectively manage submissions, especially Periodic Safety Update Reports (PSURs), is essential for compliance and efficient communication with regulatory authorities. This article serves as a comprehensive guide on the technical aspects of PSUR filings using the electronic Common Technical Document (eCTD) format, offering practical advice to regulatory affairs professionals. How to Structure a PSUR for eCTD Submissions The structure of a PSUR includes specific sections that regulatory…

Periodic Safety Update Reports: Best Practices and Compliance Checklist – regulatory and compliance consulting Periodic Safety Update Reports: Best Practices and Compliance Checklist How to Structure a Periodic Safety Update Report (PSUR) The Periodic Safety Update Report (PSUR) is a vital document in pharmacovigilance, reflecting the safety profile of a drug over time. It is essential that the report adheres to regulatory guidelines set forth by bodies such as the FDA, EMA, and WHO, ensuring that it captures the necessary data effectively. When structuring a PSUR, organizations must ensure that the report is clear, concise, and compliant. The following key…

Common Mistakes in Periodic Safety Update Reports and How to Avoid Them – master’s in quality assurance and regulatory affairs online Common Mistakes in Periodic Safety Update Reports and How to Avoid Them How to Understand the Regulatory Requirements for Periodic Safety Update Reports The first step in avoiding common pitfalls in Periodic Safety Update Reports (PSURs) is to fully grasp the regulatory landscape. Various regulatory bodies, including the FDA, EMA, and MHRA, outline specific guidelines for PSUR submissions. It’s essential to familiarize yourself with the applicable regulations, as they help define the expectations for safety data, reporting timelines, and…

Step-by-Step Implementation Guide to Periodic Safety Update Reports – financial compliance consultants Step-by-Step Implementation Guide to Periodic Safety Update Reports The preparation and submission of Periodic Safety Update Reports (PSURs) is a critical responsibility for pharmaceutical companies and regulatory compliance professionals. This guide aims to provide an in-depth step-by-step implementation process for drafting, reviewing, and submitting PSURs that align with global regulatory requirements, including those set by the FDA, EMA, MHRA, and similar agencies. By adhering to this comprehensive guide, financial compliance consultants can ensure that they meet the necessary regulations while maintaining the highest standards of pharmacovigilance. How to…

KPI and Performance Metrics for Periodic Safety Update Reports Programs – regulatory compliance audit KPI and Performance Metrics for Periodic Safety Update Reports Programs Periodic Safety Update Reports (PSURs) are crucial documents within the framework of pharmacovigilance that summarize the safety profile of a therapeutic product throughout its lifecycle. The generated insights from PSURs assist regulatory authorities in ensuring that the benefits of drug therapies outweigh their risks. In this comprehensive guide, we will explore how to effectively assess and report Key Performance Indicators (KPIs) and performance metrics related to PSURs, ensuring compliance in regulatory audits. This manual aligns with…

Outsourcing vs In-House Models for Periodic Safety Update Reports – master’s in regulatory affairs Outsourcing vs In-House Models for Periodic Safety Update Reports Periodic Safety Update Reports (PSURs) are essential documents in the realm of pharmacovigilance, providing critical information on the safety of pharmaceutical products over time. For professionals in regulatory affairs or those pursuing a master’s in regulatory affairs, understanding the nuances of the PSUR process and the implications of either in-house or outsourcing models is paramount. This article delves into the operational, regulatory, and compliance aspects of both approaches, ensuring that professionals are equipped with the necessary insights…